<DOC>
	<DOC>NCT00239616</DOC>
	<brief_summary>This is an open-label, multicenter pharmacokinetic study of HD od PD patients receiving erythropoietin. Patients were administered 100mg of iron sucrose undiluted by slow IV push over 5 minutes. Patients underwent serial blood draws and were subsequently followed for 7 days for safety endpoints.</brief_summary>
	<brief_title>Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin</brief_title>
	<detailed_description>This is an open-label, multicenter pharmacokinetic study of HD of adolescent PD patients receiving erythropoietin. Patients between the ages of 12 and 18 were administered 100mg of iron sucrose, undiluted by slow IV push over 5 minutes, and underwent serial blood draws. The patients were subsequently followed for 7 days for safety endpoints.</detailed_description>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide, saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Age between 12 and 18 History of Chronic Renal Failure requiring HD or PD Hgb &lt;/= 13 g/dL Ferritin &lt; 800 ng/ml TSAT &lt; 50% Receiving EPO Known Sensitivity to Iron Sucrose Severe Concomitant disease of the liver or cardiovascular system Serious bacterial Infection Pregnancy / Lactation Active Hepatitis Patients with Causes of iron deficiency other that Chronic Renal Failure Blood Transfusion Body Weight &lt; 25 KG Currently being treated for Asthma Received investigational drug within last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>